Alberts Cellular Therapy

Pretoria 0181

1 studies enrolling now · 2 studies all time

What they study most

Marginal Zone Lymphoma, Myelodysplastic Syndromes, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling